EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC 4.0

Predictive factors of poor outcome and mortality among anterior ischaemic stroke patients despite successful recanalisation in China: a secondary analysis of the CAPTURE trial

Guangwen Li iD, Yujie Sun, Tonghui Liu, Pengfei Yang, Ya Peng, Wenhuo Chen, Liyong Zhang, Jianfeng Chu, Dong Kuai, Zibo Wang, Wei Wu, Yun Xu und 12 weitere

BMJ Open · 2023-12 · 13 (12) · e078917

DOI: 10.1136/bmjopen-2023-078917 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift BMJ Open, online erschienen am 09.12.2023. Verfasst von Guangwen Li und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Arterial Occlusive Diseases, Brain Ischemia, Endovascular Procedures, Ischemic Stroke. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Qingdao Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This work aimed to analyse the risk factors for poor outcomes and mortality among patients with anterior large vessel occlusion (LVO) ischaemic stroke, despite successful recanalisation. Setting and participants This study conducted a secondary analysis among patients who underwent successful recanalisation in the CAPTURE trial. The trial took place between March 2018 and September 2020 at 21 sites in China. The CAPTURE trial enrolled patients who had an acute ischaemic stroke aged 18–80 years with LVO in anterior circulation.

Interventions

Thrombectomy was immediately performed using Neurohawk or the Solitaire FR after randomisation in CAPTURE trial. Rescue treatment was available for patients with severe residual stenosis caused by atherosclerosis. Primary and secondary outcome measures The primary goal was to predict poor 90-day survival or mortality within 90 days post-thrombectomy. Univariate analysis, using the χ 2 test or Fisher’s exact test, was conducted for each selected factor. Subsequently, a multivariable analysis was performed on significant factors (p≤0.10) identified through univariate analysis using the backward selection logistic regression approach.

Results

Among the 207 recruited patients, 79 (38.2%) exhibited poor clinical outcomes, and 26 (12.6%) died within 90 days post-thrombectomy. Multivariate analysis revealed that the following factors were significantly associated with poor 90-day survival: age ≥67 years, internal carotid artery (ICA) occlusion (compared with middle cerebral artery (MCA) occlusion), initial National Institutes of Health Stroke Scale (NIHSS) score ≥17 and final modified Thrombolysis in Cerebral Infarction (mTICI) score 2b (compared with mTICI 3). Additionally, the following factors were significantly associated with mortality 90 days post-thrombectomy: initial NIHSS score ≥17, ICA occlusion (compared with MCA occlusion) and recanalisation with more than one pass.

Conclusions

Age, NIHSS score, occlusion site, mTICI score and the number of passes can be independently used to predict poor 90-day survival or mortality within 90 days post-thrombectomy. Trial registration number NCT04995757 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arterial Occlusive DiseasesBrain IschemiaEndovascular ProceduresIschemic StrokeStrokeHumansInfantInfarction, Middle Cerebral ArteryRetrospective StudiesThrombectomyTreatment Outcome

Stichwörter der Autor:innen

STROKE MEDICINEStrokeStroke medicine

Autor:innen und Institutionen

  • Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Neurovascular Center, Changhai Hospital, Naval Military Medical University, Shanghai, China.
  • Department of Neurosurgery, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
  • Department of Neurology, Zhangzhou Hospital Affiliated to Fujian Medical University, Zhangzhou, China.
  • Department of Neurosurgery, Liaocheng People's Hospital Brain Hospital, Liaocheng, Shandong, China.
  • Department of Neurology, The First People's Hospital of Jining City, Jining, China.

ORCID-Profile: Guangwen Li

Förderung

  • Qingdao Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Li, G., Sun, Y., Liu, T., Yang, P., Peng, Y., Chen, W., Zhang, L., Chu, J., Kuai, D., Wang, Z., Wu, W., Xu, Y., Zhou, B., Geng, Y., Yin, C., Li, J., Wang, M., Peng, X., Xiao, Y., …, & Zhang, Y. (2023). Predictive factors of poor outcome and mortality among anterior ischaemic stroke patients despite successful recanalisation in China: a secondary analysis of the CAPTURE trial. BMJ Open, 13(12), e078917. https://doi.org/10.1136/bmjopen-2023-078917

Vancouver

Li G, Sun Y, Liu T, Yang P, Peng Y, Chen W, et al. Predictive factors of poor outcome and mortality among anterior ischaemic stroke patients despite successful recanalisation in China: a secondary analysis of the CAPTURE trial. BMJ Open. 2023;13(12):e078917. doi:10.1136/bmjopen-2023-078917

BibTeX
@article{Li2023,
  author = {Li, Guangwen and Sun, Yujie and Liu, Tonghui and Yang, Pengfei and Peng, Ya and Chen, Wenhuo and Zhang, Liyong and Chu, Jianfeng and Kuai, Dong and Wang, Zibo and Wu, Wei and Xu, Yun and Zhou, Bin and Geng, Yu and Yin, Congguo and Li, Jiang and Wang, Ming and Peng, Xiaoxiang and Xiao, Yaping and Li, Minghua and Zhang, Xianjun and Liu, Peng and Wang, Naidong and Zhang, Yong},
  title = {Predictive factors of poor outcome and mortality among anterior ischaemic stroke patients despite successful recanalisation in China: a secondary analysis of the CAPTURE trial},
  journal = {BMJ Open},
  year = {2023},
  volume = {13},
  number = {12},
  pages = {e078917},
  doi = {10.1136/bmjopen-2023-078917}
}
Kostenlos starten →